Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Century Therapeutics Inc | 2.04m | -131.39m | 144.02m | 152.00 | -- | 0.6472 | -- | 70.53 | -2.04 | -2.04 | 0.031 | 2.63 | 0.0049 | -- | -- | 13,434.21 | -31.52 | -- | -33.04 | -- | -- | -- | -6,434.23 | -- | -- | -- | 0.00 | -- | -57.01 | -- | -4.38 | -- | -- | -- |
| Repare Therapeutics Inc | 68.68m | -68.52m | 149.41m | 179.00 | -- | 0.7336 | -- | 2.18 | -1.63 | -1.63 | 1.61 | 4.80 | 0.2558 | -- | 6.34 | 383,703.90 | -25.52 | -23.40 | -30.30 | -26.37 | -- | -- | -99.76 | -162.76 | -- | -- | 0.00 | -- | -61.21 | -- | -222.91 | -- | 27.16 | -- |
| Acumen Pharmaceuticals Inc | 0.00 | -64.86m | 150.20m | 51.00 | -- | 0.6157 | -- | -- | -1.11 | -1.11 | 0.00 | 4.06 | 0.00 | -- | -- | 0.00 | -27.82 | -- | -29.32 | -- | -- | -- | -- | -- | -- | -- | 0.1075 | -- | -- | -- | -22.20 | -- | -- | -- |
| P3 Health Partners Inc | 1.40bn | -69.48m | 153.82m | 400.00 | -- | 0.4169 | -- | 0.1097 | -0.5821 | -0.5821 | 11.56 | 1.03 | 1.56 | -- | 10.97 | 3,507,143.00 | -20.51 | -- | -110.70 | -- | 0.6223 | 0.1781 | -13.17 | -56.93 | -- | -9.67 | 0.2686 | -- | 20.67 | 70.58 | 78.61 | -- | -11.20 | -- |
| Adverum Biotechnologies Inc | 0.00 | -99.86m | 155.80m | 121.00 | -- | 0.9272 | -- | -- | -7.99 | -7.99 | 0.00 | 8.08 | 0.00 | -- | -- | 0.00 | -40.33 | -36.39 | -46.64 | -39.04 | -- | -- | -- | -5,279.60 | -- | -- | 0.00 | -- | -- | 17.43 | 24.18 | -- | -0.0247 | -- |
| Achieve Life Sciences Inc | 0.00 | -27.54m | 157.97m | 22.00 | -- | 3.74 | -- | -- | -1.10 | -1.10 | 0.00 | 1.23 | 0.00 | -- | -- | 0.00 | -58.78 | -86.31 | -71.94 | -119.59 | -- | -- | -- | -- | -- | -11.79 | 0.294 | -- | -- | -- | 29.60 | -- | -14.51 | -- |
| Cellectis SA (ADR) | 25.48m | -90.71m | 158.37m | 236.00 | -- | 1.10 | -- | 6.21 | -1.93 | -2.21 | 0.542 | 2.05 | 0.0852 | -- | 2.22 | 107,983.10 | -32.81 | -21.38 | -40.55 | -26.37 | -- | -61.60 | -385.36 | -268.89 | -- | -5.89 | 0.3871 | -- | -33.35 | -5.27 | -5.77 | -- | -14.21 | -- |
| Ventyx Biosciences Inc | 0.00 | -171.30m | 162.54m | 73.00 | -- | 0.5788 | -- | -- | -2.79 | -2.79 | 0.00 | 3.97 | 0.00 | -- | -- | 0.00 | -52.07 | -- | -55.27 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -77.97 | -- | -- | -- |
| Capricor Therapeutics Inc | 27.15m | -27.95m | 164.32m | 101.00 | -- | 14.04 | -- | 6.05 | -0.9302 | -0.9302 | 0.9072 | 0.3596 | 0.6443 | -- | 59.18 | 268,833.90 | -66.31 | -54.12 | -208.71 | -75.13 | -- | -- | -102.93 | -316.25 | -- | -- | 0.2269 | -- | 886.81 | 72.02 | 23.20 | -- | 45.27 | -- |
| Immunic Inc | 0.00 | -95.31m | 164.84m | 77.00 | -- | 2.59 | -- | -- | -1.51 | -1.51 | 0.00 | 0.7058 | 0.00 | -- | -- | 0.00 | -108.78 | -72.09 | -141.92 | -80.11 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 22.25 | -- | -10.97 | -- |
| Tenaya Therapeutics Inc | 0.00 | -120.74m | 168.03m | 140.00 | -- | 1.25 | -- | -- | -1.54 | -1.54 | 0.00 | 1.70 | 0.00 | -- | -- | 0.00 | -62.89 | -- | -69.73 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.3388 | -- | -- | -- |
| Inovio Pharmaceuticals Inc | 591.86k | -121.64m | 168.25m | 122.00 | -- | 1.74 | -- | 284.27 | -5.11 | -5.11 | 0.0248 | 3.73 | 0.0032 | -- | 0.6652 | 4,851.31 | -66.32 | -59.52 | -84.33 | -71.29 | -- | -- | -20,552.24 | -4,097.36 | -- | -- | 0.00 | -- | -91.89 | -51.33 | 51.71 | -- | -31.22 | -- |
| Context Therapeutics Inc | 0.00 | -18.57m | 169.50m | 5.00 | -- | 1.68 | -- | -- | -1.06 | -1.06 | 0.00 | 1.35 | 0.00 | -- | -- | 0.00 | -28.46 | -- | -29.68 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -61.53 | -- | -- | -- |
| Seres Therapeutics Inc | 374.00k | -162.11m | 172.19m | 233.00 | -- | -- | -- | 460.40 | -1.18 | -1.18 | 0.0027 | -0.5742 | 0.001 | -- | 0.0286 | 1,605.15 | -44.53 | -41.51 | -59.82 | -54.13 | -- | -- | -43,343.58 | -170.14 | 0.889 | -17.64 | 6.65 | -- | 1,672.24 | 34.91 | 54.54 | -- | 32.72 | -- |
| Galectin Therapeutics Inc | 0.00 | -48.03m | 172.51m | 14.00 | -- | -- | -- | -- | -0.7831 | -0.7831 | 0.00 | -1.32 | 0.00 | -- | -- | 0.00 | -185.54 | -92.08 | -382.33 | -121.97 | -- | -- | -- | -- | -- | -8.59 | 8.29 | -- | -- | -- | -15.26 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Cellectis SA's reporting currency: US Dollar USD
13.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Long Focus Capital Management LLCas of 30 Jun 2024 | 4.62m | 6.41% |
| Capital Research & Management Co. (International Investors)as of 30 Jun 2024 | 1.85m | 2.56% |
| Credit Suisse Asset Management (Schweiz) AGas of 30 Jun 2024 | 1.44m | 2.00% |
| Baillie Gifford & Co.as of 30 Jun 2024 | 707.63k | 0.98% |
| Principal Global Investors LLCas of 30 Jun 2024 | 437.00k | 0.61% |
| Macquarie Investment Management Business Trustas of 30 Jun 2024 | 226.88k | 0.32% |
| KBC Asset Management NVas of 30 Jun 2024 | 163.45k | 0.23% |
| LPL Financial LLCas of 30 Jun 2024 | 91.79k | 0.13% |
| Morgan Stanley & Co. International Plcas of 30 Jun 2024 | 63.99k | 0.09% |
| Two Sigma Investments LPas of 30 Jun 2024 | 40.29k | 0.06% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
